C
Cellectar Biosciences D
D
CLRB
5.69000
USD
-0.14
(-2.47%)
مغلق
حجم التداول
2,373
الربح لكل سهم
-12
العائد الربحي
-
P/E
-0
حجم السوق
18,162,708
الأخبار المقالات
العنوان: Cellectar Biosciences Inc
القطاع: Healthcare
الصناعة: Biotechnology
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.